Arecor Therapeutics plc (AREC) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
137.50p
137.95p
270.00p
£42.11 million
137.50p
135.25p
127.50p
n/a
0.00p (0.00%) Previous:
0.00p
17,518
n/a
1,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | 2.40 | 1.16 |
Profit before tax (£m) | (10.54) | (6.95) |
Adjusted EPS (p): | (32.00) | (27.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Arecor subsidiary Tetris launching Ogluo in the Netherlands
29 February 2024 14:12
-
Arecor appoints new commercial manager to Tetris subsidiary
3 January 2024 13:44
-
Arecor inks co-development deal with global medicine company
4 December 2023 09:49
-
Publication of Full Year Financial Results delayed
3 May 2024 16:44
-
Notice of results
29 April 2024 07:00
-
BOARD CHANGE
23 April 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.